Paradigm Biocapital Advisors LP

Holdings History for Zentalis Pharmaceuticals, Inc. - Common Stock,$0.001 par value per share (ZNTL)

Symbol: ZNTL on Nasdaq
Investment type: Equity / Common Stock,$0.001 par value per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2024		-0.52%	$0	0	-944,917	-100%	$2.55	Q2 2024
31 Mar 2024	0.52%	+0.3%	$14,891,892	944,917	+544,917	+136%	$15.76	Q1 2024
31 Dec 2023	0.28%	+0.28%	$6,060,000	400,000	+400,000	NEW	$15.15	Q4 2023
30 Jun 2022		-3.5%	$0	0	-287,577	-100%	$2.55	Q2 2022
31 Mar 2022	3.5%	-0.16%	$13,269,000	287,577	-12,857	-4.3%	$46.14	Q1 2022
31 Dec 2021	7.2%	0%	$25,254,000	300,434	0		$84.06	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.